Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT07439991 2026-02-27

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Recruiting

900 enrolled

Classical hematologyThoracic

Disease, Lung Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT07288632 2025-12-17

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Recruiting

500 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT06950697 2025-04-30

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Recruiting

2,400 enrolled

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT03870464 2024-05-07

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

Active not recruiting

150 enrolled

CNSClassical hematologyThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT06314763 2024-04-30

ROSIE

Phase 4 Completed

21 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT03090880 2022-11-17

PROVE

Phase 3 Terminated

59 enrolled

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT02334007 2018-09-18

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Phase 1/2 Completed

102 enrolled

Classical hematologyThoracic

Lung Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03581708 2018-07-10

RIVAL

Unknown

1,400 enrolled

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Phase NA Completed

362 enrolled

Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

NCT00476216 2014-03-05

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

23 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT00192829 2007-04-11

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Unknown

100 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thrombosis, Thrombophilia, Venous Thromboembolism

Clinical Trials

AmiCARE

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

ROSIE

PROVE

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

RIVAL

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma